Cargando…
Coagulopathy in Acute Promyelocytic Leukemia: Can We Go Beyond Supportive Care?
Acute promyelocytic leukemia (APL) is characterized by frequent complications due to a distinct coagulopathy. While advances in treatments have improved long-term survival, hemorrhagic and thrombotic complications remain the most common causes of death and morbidity. Improved understanding of the me...
Autores principales: | Hambley, Bryan C., Tomuleasa, Ciprian, Ghiaur, Gabriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415964/ https://www.ncbi.nlm.nih.gov/pubmed/34485349 http://dx.doi.org/10.3389/fmed.2021.722614 |
Ejemplares similares
-
The Coagulopathy of Acute Promyelocytic Leukemia: An Updated Review of Pathophysiology, Risk Stratification, and Clinical Management
por: Hermsen, Jack, et al.
Publicado: (2023) -
Editorial: Modern Approaches to Hemophilia Management: Gene Therapy and Beyond
por: Coriu, Daniel, et al.
Publicado: (2022) -
Charting a course through the acute promyelocytic leukemia (APL)-like nebula: the enigmatic cousins of APL
por: Ghiaur, Alexandra, et al.
Publicado: (2023) -
FLT3-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification
por: Li, Andrew Y., et al.
Publicado: (2021) -
Increased body mass index is a risk factor for acute promyelocytic leukemia
por: Kashanian, Sarah M., et al.
Publicado: (2021)